Findings published by The BMJ reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental disorders such as ADHD and autism in children, and ...
Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.
Alembic Pharma receives US FDA approval for lamotrigine orally disintegrating tablets USP, 25 mg, 50 mg, 100 mg & 200 mg: Our Bureau, Mumbai Thursday, February 26, 2026, 14:15 Hrs ...
April 26, 2011 — The US Food and Drug Administration has approved lamotrigine extended release for conversion to monotherapy for partial seizures. This is a new indication for the GlaxoSmithKline ...
Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Lamotrigine ...
The study, published in Lancet Neurology, detailed the "head-to-head" trial implemented by the researchers to test two drugs, mexiletine and lamotrigine, on people with the condition. The trial, which ...
Findings published by The BMJ today reinforce previous research linking use of the antiseizure drug valproate during pregnancy to neurodevelopmental ...
Alembic Pharmaceuticals has received final approval from the USFDA for its Lamotrigine orally disintegrating tablets used in the treatment of various seizure disorders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results